Your browser doesn't support javascript.
loading
Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance.
Lyczek, Agatha; Berger, Benedict-Tilman; Rangwala, Aziz M; Paung, YiTing; Tom, Jessica; Philipose, Hannah; Guo, Jiaye; Albanese, Steven K; Robers, Matthew B; Knapp, Stefan; Chodera, John D; Seeliger, Markus A.
Afiliação
  • Lyczek A; Department of Pharmacological Sciences, Stony Brook University School of Medicine, Stony Brook, NY 11794.
  • Berger BT; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt am Main 60438, Germany.
  • Rangwala AM; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Frankfurt am Main 60438, Germany.
  • Paung Y; Department of Pharmacological Sciences, Stony Brook University School of Medicine, Stony Brook, NY 11794.
  • Tom J; Department of Pharmacological Sciences, Stony Brook University School of Medicine, Stony Brook, NY 11794.
  • Philipose H; Department of Pharmacological Sciences, Stony Brook University School of Medicine, Stony Brook, NY 11794.
  • Guo J; Department of Pharmacological Sciences, Stony Brook University School of Medicine, Stony Brook, NY 11794.
  • Albanese SK; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
  • Robers MB; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
  • Knapp S; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
  • Chodera JD; Research and Development Department, Promega Corporation, Fitchburg, WI 53711.
  • Seeliger MA; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt am Main 60438, Germany.
Proc Natl Acad Sci U S A ; 118(46)2021 11 16.
Article em En | MEDLINE | ID: mdl-34750265
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Fusão bcr-abl / Resistencia a Medicamentos Antineoplásicos / Mesilato de Imatinib / Mutação Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Fusão bcr-abl / Resistencia a Medicamentos Antineoplásicos / Mesilato de Imatinib / Mutação Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2021 Tipo de documento: Article